Applied Therapeutics
APLT
APLT was delisted on the 2nd of February, 2026.
13 hedge funds and large institutions have $18.1M invested in Applied Therapeutics in 2019 Q2 according to their latest regulatory filings, with 13 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
12.88% more ownership
Funds ownership: 0% → 12.88% (+13%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$5.55M |
| 2 |
KCM
Knoll Capital Management
Miami,
Florida
|
+$4.42M |
| 3 |
EMFAT
Emerald Mutual Fund Advisers Trust
Leola,
Pennsylvania
|
+$4.36M |
| 4 |
Alkeon Capital Management
New York
|
+$3.79M |
| 5 |
SI
Sofinnova Investments
Menlo Park,
California
|
+$1.34M |
Top Sellers
APLT Hedge Fund Activity: Q2 2019 in Review
13 of the 4,625 institutional investors tracked by Wall St. Rank reported a position in Applied Therapeutics (APLT) for Q2 2019, worth a combined $18.1M.
Buyers outnumbered sellers: 13 funds opened new APLT positions and 0 closed out — a net gain of 13 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Fidelity Investments, opening a new position worth an estimated $5.55M.
- 13 institutional investors held Applied Therapeutics (APLT) as of Q2 2019, up from 0 in Q1 2019.
- Funds reported $18.1M of Applied Therapeutics stock for Q2 2019.
- 13 funds opened new Applied Therapeutics positions in Q2 2019 and 0 closed out, a net change of +13 holders.
- The largest Applied Therapeutics buyer in Q2 2019 was Fidelity Investments, an estimated $5.55M added.
Based on aggregated 13F filings for Q2 2019.